HYDERABAD: Unveiling BioAsia 2024, with the theme ‘Data and AI – Redefining Possibilities’, slated for February 26 and 28, IT and Industries Minister KT Rama Rao (KTR) mentioned that it spoke volumes about Hyderabad’s distinctive convergence of expertise and life sciences, shaping a brand new period of healthcare innovation.

He introduced the eagerly awaited 21 version of BioAsia 2024 a unprecedented platform the place knowledge and Artificial Intelligence (AI) converge to redefine prospects throughout the life sciences and healthcare sectors, in Hyderabad on Saturday

The BioAsia 2024 would discover the pivotal function of data-driven applied sciences and synthetic intelligence in shaping the way forward for healthcare, prescribed drugs, and biotechnology. As the world more and more harnesses the facility of digital innovation, the theme aptly underscored the immense potential on the intersection of expertise and life sciences.

Speaking about BioAsia 2024, KTR mentioned: “BioAsia has always been a catalyst for transformative ideas and partnerships. The theme of data and AI speaks to Hyderabad’s unique convergence of technology and life sciences, shaping a new era of healthcare innovation. This flagship event is a testament to our commitment to fostering collaborations that drive progress and impact on a global scale. With the world’s leading minds converging in Hyderabad, we are set to explore the uncharted frontiers of this transformative era.”

“Hyderabad is the place where technology meets biology and data sciences meet life sciences,” said KTR capturing the essence of the city’s prowess in marrying cutting-edge technology with life sciences expertise.

BioAsia consistently rose as a global platform that fostered meaningful dialogues among industry leaders, policymakers, researchers, and innovators. BioAsia 2024 would elevate this legacy by assembling influential global leaders and participants from more than 50 countries, fostering collaborations and partnerships that transcend geographical boundaries.

“In an era marked by breakthroughs in genomics, precision medicine, and digital health, the convergence of data and AI promises to reshape research, diagnostics, treatment, and patient care. This year’s theme encapsulates the profound impact of data-driven technologies and artificial intelligence on the trajectory of healthcare, biotechnology, pharmaceuticals, and medical devices. BioAsia 2024 will unlock new dimensions in the world of life sciences and healthcare through the lens of Data and AI. It’s an event not to be missed” mentioned Shakthi M Nagappan, CEO of Telangana Lifesciences and BioAsia, Government of Telangana.

BioAsia 2024 could be a landmark occasion that will set the stage for significant conversations, improvements, and collaborations, driving the life sciences and healthcare sectors to new horizons.

“BioAsia 2024 is the embodiment of our vision to harness the potential of data and AI to redefine healthcare possibilities globally. BioAsia is the perfect platform to explore the synergy between data, AI, and life sciences, propelling us into a future of transformative healthcare” mentioned Jayesh Ranjan, Principal Secretary (I&C), Telangana Government.

“Artificial intelligence and machine learning are exerting a transformative effect on the life sciences industry. Gen AI, the recent buzzword is a new addition to the list of transformative forces. Though at an early stage of adoption, the life sciences industry is likely to find numerous future use cases of these transformative technologies which could be the realm of imagination today. BioAsia 2024’s theme,” mentioned Suresh Subramanian, Partner and National Life Sciences Leader, Ernst & Young LLP.